• LAST PRICE
    3.8800
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    3.5600/ 1
  • Ask / Lots
    4.1100/ 2
  • Open / Previous Close
    0.0000 / 3.8800
  • Day Range
    ---
  • 52 Week Range
    Low 2.7001
    High 17.5000
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 3.76
TimeVolumeABEO
09:32 ET92403.74
09:33 ET41003.73
09:35 ET27003.74
09:37 ET34053.73
09:39 ET88993.73
09:42 ET44983.7307
09:44 ET3003.73
09:46 ET6003.75
09:48 ET5003.8
09:50 ET72613.78
09:51 ET7003.78
09:53 ET65003.8
09:55 ET52003.77
09:57 ET2503.7609
10:00 ET5003.8
10:02 ET1003.76
10:08 ET25913.76
10:09 ET1003.76
10:22 ET1003.775
10:26 ET11783.75
10:27 ET2003.74
10:33 ET9393.76
10:36 ET89963.76
10:38 ET56003.77
10:42 ET3003.75
10:44 ET2493.75
10:51 ET4403.75
10:56 ET1003.79
11:00 ET1003.81
11:03 ET1003.8075
11:05 ET1003.7675
11:07 ET1003.7903
11:09 ET7003.83
11:14 ET1003.85
11:18 ET1003.85
11:20 ET2003.815
11:21 ET1003.81
11:23 ET27003.78
11:27 ET9953.79
11:30 ET1003.805
11:32 ET1003.805
11:34 ET121703.77
11:36 ET4003.79
11:41 ET2003.74
11:43 ET2003.79
11:45 ET2003.81
11:50 ET21003.78
11:52 ET1003.76
11:54 ET51753.78
11:56 ET3003.77
11:57 ET2003.76
11:59 ET2003.78
12:03 ET1003.8
12:08 ET1003.76
12:10 ET2003.775
12:12 ET13003.8
12:14 ET1003.79
12:15 ET1333.79
12:32 ET2003.77
12:35 ET8453.77
12:37 ET1003.75
12:39 ET49633.79
12:44 ET2003.77
12:48 ET3003.77
12:50 ET1003.785
12:51 ET2123.77
12:53 ET21703.81
12:55 ET60003.8199
12:57 ET31013.85
01:00 ET50003.85
01:02 ET26573.81
01:04 ET8003.81
01:06 ET4003.81
01:08 ET6003.85
01:13 ET10003.85
01:20 ET18003.87
01:27 ET5003.855
01:33 ET1003.85
01:36 ET2443.86
01:40 ET5083.86
01:49 ET52563.9
01:51 ET1003.88
01:54 ET3003.88
01:56 ET1003.87
02:02 ET1003.8708
02:05 ET3003.9
02:07 ET1003.885
02:12 ET4003.88
02:14 ET19003.92
02:18 ET1003.9
02:21 ET1003.9078
02:23 ET1003.91
02:27 ET14193.95
02:30 ET267993.8601
02:32 ET175223.82
02:34 ET8003.79
02:36 ET9003.8
02:41 ET7963.8655
02:43 ET6813.8652
02:45 ET1003.87
02:50 ET1003.87
02:52 ET13003.88
02:54 ET1003.86
02:56 ET5003.865
03:01 ET13703.87
03:08 ET8003.91
03:15 ET1003.9
03:17 ET3003.885
03:19 ET1203.8938
03:21 ET15063.88
03:30 ET1003.9
03:32 ET8003.86
03:35 ET1003.855
03:37 ET1003.89
03:42 ET1003.89
03:44 ET1003.89
03:46 ET1003.87
03:48 ET9003.865
03:50 ET13383.87
03:51 ET1003.875
03:53 ET1003.89
03:55 ET4003.87
04:00 ET59033.88
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesABEO
Abeona Therapeutics Inc
66.6M
-0.2x
---
United StatesCRDF
Cardiff Oncology Inc
66.1M
-1.6x
---
United StatesSURF
Surface Oncology Inc
55.9M
-0.7x
---
United StatesLIFE
aTyr Pharma Inc
66.1M
-1.4x
---
United StatesIMPL
Impel Pharmaceuticals Inc
69.8M
-0.6x
---
United StatesXLO
Xilio Therapeutics Inc
65.7M
-0.8x
---
As of 2022-12-02

Company Information

Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company that develops gene and cell therapies for life-threatening rare genetic diseases. The Company’s lead clinical programs consist of EB-101, which is an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa (RDEB) and ABO-102, which is an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A (MPS IIIA). The Company is focused on to develop additional AAV-based gene therapies designed to treat ophthalmic and other diseases and AAV-based gene therapies using the AIM Capsid platform that has a license from the University of North Carolina at Chapel Hill and internal AAV vector research programs. It is applying AIM Capsid Technology to develop in-vivo gene therapies.

Contact Information

Headquarters
1330 Avenue of the Americas Fl 33NEW YORK, NY, United States 10019-5442
Phone
646-813-4701
Fax
302-655-5049

Executives

Chairman of the Board
Michael Amoroso
President, Chief Executive Officer, Director
Vishwas Seshadri
Chief Financial Officer, Chief Accounting Officer
Joseph Vazzano
General Counsel
Brendan O Malley
Director
Christine Silverstein

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$66.6M
Revenue (TTM)
$4.3M
Shares Outstanding
17.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.21
EPS
$-18.26
Book Value
$8.73
P/E Ratio
-0.2x
Price/Sales (TTM)
15.3
Price/Cash Flow (TTM)
---
Operating Margin
-1,947.33%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.